Business Description
Zhejiang Chemsyn Pharm Co Ltd
ISIN : CNE100006CY8
Description
Zhejiang Chemsyn Pharm Co Ltd is engaged in research& development, production and sales of veterinary raw materials, pharmaceutical raw materials and intermediates. Its products category includes API, Sulfa API, Intermediates. It also includes N-Acetylsulfanilyl Chloride, Sulfanilamide, Sulfachloropyridazine Sodium, Sulfachloropyrazine Sodium.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | 169.72 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 23.82 | |||||
| Beneish M-Score | -3.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year FCF Growth Rate | -31 | |||||
| 3-Year Book Growth Rate | 8.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.66 | |||||
| 9-Day RSI | 60.75 | |||||
| 14-Day RSI | 57.52 | |||||
| 3-1 Month Momentum % | -33.02 | |||||
| 6-1 Month Momentum % | 25 | |||||
| 12-1 Month Momentum % | -6.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.25 | |||||
| Quick Ratio | 12.55 | |||||
| Cash Ratio | 11.53 | |||||
| Days Inventory | 115.03 | |||||
| Days Sales Outstanding | 57.01 | |||||
| Days Payable | 53.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.77 | |||||
| Dividend Payout Ratio | 0.69 | |||||
| Forward Dividend Yield % | 2.77 | |||||
| 5-Year Yield-on-Cost % | 2.77 | |||||
| 3-Year Average Share Buyback Ratio | -12.6 | |||||
| Shareholder Yield % | 2.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.92 | |||||
| Operating Margin % | 31.5 | |||||
| Net Margin % | 31.01 | |||||
| FCF Margin % | 0.61 | |||||
| ROE % | 10.39 | |||||
| ROA % | 9.82 | |||||
| ROIC % | 24.42 | |||||
| 3-Year ROIIC % | -0.68 | |||||
| ROC (Joel Greenblatt) % | 37.78 | |||||
| ROCE % | 10.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.18 | |||||
| PE Ratio without NRI | 25.25 | |||||
| Shiller PE Ratio | 20.01 | |||||
| Price-to-Owner-Earnings | 176.73 | |||||
| PEG Ratio | 0.69 | |||||
| PS Ratio | 7.96 | |||||
| PB Ratio | 2.31 | |||||
| Price-to-Tangible-Book | 2.37 | |||||
| Price-to-Free-Cash-Flow | 918.93 | |||||
| Price-to-Operating-Cash-Flow | 57.98 | |||||
| EV-to-EBIT | 24.87 | |||||
| EV-to-EBITDA | 24.69 | |||||
| EV-to-Revenue | 7.84 | |||||
| EV-to-FCF | 1275.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.51 | |||||
| Price-to-Graham-Number | 1.62 | |||||
| Price-to-Net-Current-Asset-Value | 3.08 | |||||
| Price-to-Net-Cash | 3.59 | |||||
| Earnings Yield (Greenblatt) % | 4.02 | |||||
| FCF Yield % | 0.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Chemsyn Pharm Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 165.413 | ||
| EPS (TTM) (Â¥) | 0.73 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 58 | ||
| 14-Day RSI | 57.52 | ||
| 14-Day ATR (Â¥) | 0.747715 | ||
| 20-Day SMA (Â¥) | 17.3585 | ||
| 12-1 Month Momentum % | -6.98 | ||
| 52-Week Range (Â¥) | 11.7 - 25.27 | ||
| Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Chemsyn Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Chemsyn Pharm Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Chemsyn Pharm Co Ltd Frequently Asked Questions
What is Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)'s stock price today?
The current price of BJSE:870656 is ¥18.08. The 52 week high of BJSE:870656 is ¥25.27 and 52 week low is ¥11.70.
When is next earnings date of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)?
The next earnings date of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) is .
Does Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) is 2.77% (As of Today), Highest Dividend Payout Ratio of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) was 0.69. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) is 2.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers